河马通路在抗PD-L1耐药癌症中的癌症相关纤维细胞中受到调节
Juliette Roels1, Hamid Ghaedi2, Jayaram Kancherla3
1Genentech South San Francisco, California United States.
Cancer research
|March 5, 2026
概括
研究人员确定了Hippo路径是固体瘤免疫疗法耐药性的关键. 与癌症相关的纤维细胞 (而不是癌细胞) 的失调驱动了耐药性,为改善癌症治疗提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 免疫疗法改善了癌症患者的治疗结果,但抗药性仍然是一个挑战.
- 识别耐药机制对于开发有效的无化疗癌症治疗至关重要.
研究的目的:
- 在固体瘤中调查分子形状和免疫疗法耐药性之间的关联.
- 确定新的治疗点,以克服对抗PD-L1治疗的耐药性.
主要方法:
- 整合了来自2800名膀癌患者的RNA测序数据 (IMvigor试验) 和来自200个样本的单细胞数据.
- 开发了Firmament工具来分析来自各种单细胞研究的1亿多个细胞的基因签名.
- 专注于对阿特佐利祖马布 (抗PD-L1疗法) 的耐药性.
主要成果:
- 确定了Hippo路径与膀和其他固体瘤的免疫疗法耐药性关键相关.
- 在癌症关联纤维细胞 (CAF) 中发现的Hippo通路失调,而不是癌细胞,驱动YAP/TAZ信号传递.
- 在CAF中抑制YAP信号减少了肌纤维细胞基因表达和降低了CAF收缩性.
结论:
- 河马通路,特别是其在CAF中的失调,是免疫疗法耐药性的关键机制.
- 针对CAF中的YAP信号提供了一个潜在的治疗策略,以提高免疫检查点抑制剂的有效性.
- 研究结果为开发组合疗法提供了见解,以改善固体瘤患者的治疗结果.
更多相关视频
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
20.8K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
7.5K
相关概念视频
Interactions Between Signaling Pathways
7.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Hedgehog Signaling Pathway
10.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.3K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
